Cargando…
Safeguarding COVID-19 and cancer management: drug design and therapeutic approach
Recent clinical cohort studies have highlighted that there is a three-fold greater SARS-Cov-2 infection risk in cancer patients, and overall mortality in individuals with tumours is increased by 41% with respect to general COVID-19 patients. Thus, access to therapeutics and intensive care is comprom...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
F1000 Research Limited
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445946/ https://www.ncbi.nlm.nih.gov/pubmed/37645153 http://dx.doi.org/10.12688/openreseurope.13841.1 |